TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionThe relationship between vasculogenic mimicry and epithelial-mesenchymal transitionsTransforming growth factor β as regulator of cancer stemness and metastasis14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinMicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasionChemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinomaCCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breastEMT and inflammation: inseparable actors of cancer progression.Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system.G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion.CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal TransitionMicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling.Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis.The lymphatic system and pancreatic cancer.CCR7 enhances the angiogenic capacity of esophageal squamous carcinoma cells in vitro via activation of the NF-κB/VEGF signaling pathway.Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses.The molecular basis of breast cancer pathological phenotypes.Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis.Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulationThe p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.Network analysis of EMT and MET micro-RNA regulation in breast cancer.Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells.TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.Notch signaling molecule is involved in the invasion of MiaPaCa2 cells induced by CoCl2 via regulating epithelial‑mesenchymal transition.α4β7+ CD4+ effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFβ1 during HIV-1 infection.
P2860
Q26745545-602917D3-71EF-4BE2-8751-419DE52F8455Q26749398-7B71D3CA-C712-42B2-AB4F-9CFC1EC4438DQ28077319-71F22FF8-F9DD-4846-AB13-59C717562961Q28385396-8555072C-5924-4966-A493-1A6B1EF56CA3Q30352893-0654E49C-659A-4310-BC4E-815678E97532Q33593895-7C24704D-58A4-4B27-876E-BE4559D5BEA7Q33679655-12A1AF99-35A3-45CE-B209-9E8E7636F60DQ33702388-9AFC4B32-EFE0-400D-BF9D-ABCF6F183371Q33737278-C7CBE32F-8925-4107-9BC5-D36AFDF0A2FEQ33779480-0A466313-1FBB-40F1-A26F-5F405BC90A20Q33869755-E5511859-8530-4758-8523-B1E206BA9CD2Q33869764-81E6CF53-B3E1-4D0A-AB7D-F61A3B139BA2Q35980816-C633393A-CEB0-4602-87EA-641490DBC1FBQ36257841-63997672-BF71-48D3-92C6-6E851AFD0A42Q36965198-74AFA965-FC85-493D-A8A3-CF130DE3DD9EQ37046438-0916DCAE-3196-42CB-9C03-3002B8B27657Q37210064-778EB8D5-9724-4DD8-92CD-83BE1B6CA811Q37590613-5D4FE386-5852-477B-B2CD-321FF03484CFQ37603252-78E1479B-D6A7-4575-9AA5-8F9F964D3706Q37692511-42DFC506-0CB6-4C5B-A66C-B5D456E4AB6CQ38689578-D9852B39-7D2E-4F6B-B095-6DD44B156839Q38695009-74E48F66-D627-47F8-B3E1-6D0815BAE0CDQ38790790-0766B378-4B4A-4A71-9738-0821E30ECAF4Q38924208-ECBA4C91-BE77-49C9-97AC-94927D37CE18Q39063008-4DA216F2-1F99-41C1-9C2C-4594BCC4B84BQ39175548-653D217C-A8AF-4256-B647-1F2B5445FF58Q39244506-1F074D4F-2F9C-4770-8D53-D3D6B677DCF2Q39706220-70ED1300-120D-4F28-84FF-B591BA37F558Q40047502-05C18958-B39B-4657-913F-94CE10105633Q41036251-502A04A4-0F67-4ED8-B93B-757946510C6BQ41382123-A50C58B5-2A78-4DCE-9D6C-8469E78D96E3Q41547499-4B955219-C8B6-4A06-9E43-EA41FDE4C5C6Q42371230-10529885-DAEC-4E57-A12C-7881DCAF1F79Q42659792-E9C285A8-BFDA-4E44-83A6-1B1E63128754Q47118235-DCE35755-CC6B-4C23-B47F-FEA115DD0611Q47152563-7ABF1CB1-2AB9-444C-A756-EE465AA19DC5Q47428579-78011080-E843-4A39-85E9-BA3312DCBCB4Q48199906-49A8A75F-0E0A-48C8-BF9E-B3C147D02A32Q48515386-F3E14B0B-A298-4FF9-990C-14EA9D8D44C5Q49545801-A53319B6-271B-4758-BCEE-CD0396EE2201
P2860
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@ast
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@en
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@nl
type
label
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@ast
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@en
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@nl
prefLabel
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@ast
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@en
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
TGF-β1-induced EMT promotes ta ...... CCR7/CCL21-mediated chemotaxis
@en
P2093
A-M Georgoudaki
C M Nelson
J Johansson
J S Alexander
K Hagikura
M C I Karlsson
P2860
P2888
P304
P3181
P356
10.1038/ONC.2015.133
P407
P577
2015-05-11T00:00:00Z
P5875
P6179
1034053792